|
Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
|
May 2013
|
Int J Hematol
|
aplastic anemia
|
|
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes.
|
May 2013
|
Am J Hematol
|
myelodysplastic syndromes (MDS)
|
|
Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype.
|
May 2013
|
Genes Chromosomes Cancer
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes and autoimmune diseases-Case series and review of literature.
|
May 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Prognostic role of immunohistochemical analysis of 5mc in Myelodysplastic Syndromes.
|
May 2013
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: What do hospitalists need to know?
|
May 2013
|
J Hosp Med
|
myelodysplastic syndromes (MDS)
|
|
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Epigenetic alterations and microRNAs: New players in the pathogenesis of myelodysplastic syndromes.
|
May 2013
|
Epigenetics
|
myelodysplastic syndromes (MDS)
|
